Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 55111-466

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 55111-466). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Packaging label for Metoprolol Succinate Extended-Release Tablets USP, 25 mg, by Dr. Reddy's Laboratories Limited. The label indicates the product is prescription-only and contains 100 tablets (10 x 10 unit-dose). Storage instructions and warnings are noted, with emphasis on keeping out of reach of children and storing at controlled room temperature.*

FDA Label Image

Carton2 (Carton2)

Cardboard carton label for Metoprolol Succinate Extended-Release Tablets USP, 50 mg, by Dr. Reddy's Laboratories Limited. The label states Rx only, package contains 100 tablets (10 blister cards each of 10 tablets). Storage instructions and warnings are included, and the label features the Dr. Reddy's logo with manufacturer address in India.*

FDA Label Image

Container1 (Container1)

Label for Metoprolol Succinate Extended-Release Tablets USP, 25 mg, showing a count of 100 tablets. The label includes the NDC number, usage warnings, storage instructions, and indicates the product is Rx Only. The labeler is Dr. Reddy's Laboratories Limited, India.*

FDA Label Image

Container2 (Container2)

Metoprolol Succinate Extended-Release Tablets USP, 50 mg, bottle label for 100 tablets by Dr. Reddy's Laboratories Limited. The label includes dosage form, strength, quantity, storage instructions, warnings, and barcode information.*

FDA Label Image

Figure (Figure)

A forest plot chart titled "Results for Subgroups in MERIT-HF" displaying relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. Various subgroups are listed on the vertical axis, including geographic location, NYHA class, ejection fraction, etiology, sex, race, history of MI, diabetes status, hypertension status, and heart rate. Horizontal axes represent relative risk values ranging from 0 to 2, with markers indicating favorability toward metoprolol succinate extended-release tablets or placebo.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of metoprolol succinate showing the molecular composition and bonding arrangement of the active ingredient components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.